1. Home
  2. NKTR vs CTGO Comparison

NKTR vs CTGO Comparison

Compare NKTR & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • CTGO
  • Stock Information
  • Founded
  • NKTR 1990
  • CTGO 2009
  • Country
  • NKTR United States
  • CTGO United States
  • Employees
  • NKTR N/A
  • CTGO N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • NKTR Health Care
  • CTGO Basic Materials
  • Exchange
  • NKTR Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • NKTR 238.7M
  • CTGO 255.7M
  • IPO Year
  • NKTR 1994
  • CTGO N/A
  • Fundamental
  • Price
  • NKTR $1.32
  • CTGO $19.47
  • Analyst Decision
  • NKTR Buy
  • CTGO Strong Buy
  • Analyst Count
  • NKTR 4
  • CTGO 1
  • Target Price
  • NKTR $2.50
  • CTGO $37.00
  • AVG Volume (30 Days)
  • NKTR 1.1M
  • CTGO 97.8K
  • Earning Date
  • NKTR 11-05-2024
  • CTGO 11-12-2024
  • Dividend Yield
  • NKTR N/A
  • CTGO N/A
  • EPS Growth
  • NKTR N/A
  • CTGO N/A
  • EPS
  • NKTR N/A
  • CTGO N/A
  • Revenue
  • NKTR $93,157,000.00
  • CTGO N/A
  • Revenue This Year
  • NKTR N/A
  • CTGO N/A
  • Revenue Next Year
  • NKTR N/A
  • CTGO $15.50
  • P/E Ratio
  • NKTR N/A
  • CTGO N/A
  • Revenue Growth
  • NKTR 6.17
  • CTGO N/A
  • 52 Week Low
  • NKTR $0.41
  • CTGO $14.03
  • 52 Week High
  • NKTR $1.93
  • CTGO $25.32
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 54.62
  • CTGO 50.43
  • Support Level
  • NKTR $1.24
  • CTGO $17.80
  • Resistance Level
  • NKTR $1.42
  • CTGO $19.27
  • Average True Range (ATR)
  • NKTR 0.09
  • CTGO 0.65
  • MACD
  • NKTR 0.01
  • CTGO 0.08
  • Stochastic Oscillator
  • NKTR 67.74
  • CTGO 68.80

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's primary focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Tetlin Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska.

Share on Social Networks: